Published in Infect Immun on December 01, 1983
Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev (1999) 12.90
Monocyte-mediated defense against microbial pathogens. Annu Rev Immunol (2008) 7.21
Pathogenesis of Aspergillus fumigatus in Invasive Aspergillosis. Clin Microbiol Rev (2009) 3.10
Aspergillus fumigatus triggers inflammatory responses by stage-specific beta-glucan display. PLoS Pathog (2005) 3.01
Killing of Aspergillus fumigatus by alveolar macrophages is mediated by reactive oxidant intermediates. Infect Immun (2003) 2.88
Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus. J Exp Med (1997) 2.82
Therapeutic concentrations of glucocorticoids suppress the antimicrobial activity of human macrophages without impairing their responsiveness to gamma interferon. J Clin Invest (1985) 2.22
Early neutrophil recruitment and aggregation in the murine lung inhibit germination of Aspergillus fumigatus Conidia. Infect Immun (2006) 1.71
Granulocyte colony-stimulating factor and azole antifungal therapy in murine aspergillosis: role of immune suppression. Antimicrob Agents Chemother (1998) 1.27
Early events in macrophage killing of Aspergillus fumigatus conidia: new flow cytometric viability assay. Clin Diagn Lab Immunol (2001) 1.21
Cerebrospinal fluid macrophage response to experimental cryptococcal meningitis: relationship between in vivo and in vitro measurements of cytotoxicity. Infect Immun (1988) 1.19
Innate immunity to Aspergillus species. Clin Microbiol Rev (2009) 1.19
Distinct responses of human monocyte subsets to Aspergillus fumigatus conidia. J Immunol (2009) 1.18
Oxygen-independent killing by alveolar macrophages. J Exp Med (1986) 1.11
Acquired immunity in experimental murine aspergillosis is mediated by macrophages. Infect Immun (1993) 1.07
Intracellular acid phosphatase content and ability of different macrophage populations to kill Nocardia asteroides. Infect Immun (1985) 1.06
Coevolution of TH1, TH2, and TH17 responses during repeated pulmonary exposure to Aspergillus fumigatus conidia. Infect Immun (2010) 1.05
Nonoxidative microbicidal activity in normal human alveolar and peritoneal macrophages. Infect Immun (1987) 1.01
Activation of pulmonary macrophages for fungicidal activity by gamma-interferon or lymphokines. Clin Exp Immunol (1987) 1.00
Accumulation of amphotericin B in human macrophages enhances activity against Aspergillus fumigatus conidia: quantification of conidial kill at the single-cell level. Antimicrob Agents Chemother (1998) 0.98
Neutrophil chemotactic responses induced by fresh and swollen Rhizopus oryzae spores and Aspergillus fumigatus conidia. Infect Immun (1985) 0.94
Necessary and sufficient role for T helper cells to prevent fungal dissemination in allergic lung disease. Infect Immun (2011) 0.93
Gamma-interferon restores listericidal activity and concurrently enhances release of reactive oxygen metabolites in dexamethasone-treated human monocytes. J Clin Invest (1988) 0.89
Germination of Aspergillus fumigatus inside avian respiratory macrophages is associated with cytotoxicity. Vet Res (2012) 0.86
Effect of lung surfactant collectins on bronchoalveolar macrophage interaction with Blastomyces dermatitidis: inhibition of tumor necrosis factor alpha production by surfactant protein D. Infect Immun (2006) 0.85
Macrophage mitochondrial and stress response to ingestion of Cryptococcus neoformans. J Immunol (2015) 0.79
Schistosoma mansoni larvicidal activity of murine bronchoalveolar lavage cells. Infect Immun (1990) 0.79
Gliotoxin Suppresses Macrophage Immune Function by Subverting Phosphatidylinositol 3,4,5-Trisphosphate Homeostasis. MBio (2016) 0.77
Therapy of murine pulmonary aspergillosis with antibody-alliinase conjugates and alliin. Antimicrob Agents Chemother (2009) 0.77
Influence of amphotericin B and amphotericin B colloidal dispersion on the functions of human phagocytes in defence against Aspergillus species. Eur J Clin Microbiol Infect Dis (2007) 0.77
Immunological aspects of Candida and Aspergillus systemic fungal infections. Interdiscip Perspect Infect Dis (2013) 0.76
Assessing anti-fungal activity of isolated alveolar macrophages by confocal microscopy. J Vis Exp (2014) 0.75
Neutrophil Interactions Stimulate Evasive Hyphal Branching by Aspergillus fumigatus. PLoS Pathog (2017) 0.75
Nebulised amphotericin B-polymethacrylic acid nanoparticle prophylaxis prevents invasive aspergillosis. Nanomedicine (2015) 0.75
Isolation of lymphocytes, granulocytes and macrophages. Scand J Immunol (1976) 7.06
Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes. J Clin Invest (1982) 4.71
Hydrogen peroxide metabolism in human monocytes during differentiation in vitro. J Clin Invest (1981) 4.46
Lysozyme content of alveolar and peritoneal macrophages from the rabbit. J Immunol (1961) 3.22
Damage to hyphal forms of fungi by human leukocytes in vitro. A possible host defense mechanism in aspergillosis and mucormycosis. Am J Pathol (1978) 2.66
Interaction of Aspergillus fumigatus Spores with Human Leukocytes and Serum. Infect Immun (1970) 1.95
Fungicidal activity of rabbit alveolar and peritoneal macrophages against Candida albicans. Infect Immun (1980) 1.79
Lysosomal stability during phagocytosis of Aspergillus flavus spores by alveolar macrophages of cortisone-treated mice. Science (1968) 1.35
Enzymatic basis for bioenergetic differences of alveolar versus peritoneal macrophages and enzyme regulation by molecular O2. J Clin Invest (1977) 1.29
Mechanical control of hospital ventilation and Aspergillus infections. Am Rev Respir Dis (1972) 1.26
The pathogenesis of experimental pulmonary aspergillosis. An ultrastructural study of alveolar macrophages after phagocytosis of a flavus spores in vivo. Am J Pathol (1971) 1.25
Immunologic studies of disseminated infection with Aspergillus fumigatus in the nude mouse. J Infect Dis (1981) 1.20
Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigattors. N Engl J Med (1992) 8.38
Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes. J Clin Invest (1982) 4.71
Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation (1997) 4.41
Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli. N Engl J Med (1982) 4.28
Plasmid transfer from Escherichia coli to Bacteroides fragilis: differential expression of antibiotic resistance phenotypes. Proc Natl Acad Sci U S A (1984) 3.85
Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes. J Infect Dis (1993) 3.75
Expression in Escherichia coli of cryptic tetracycline resistance genes from bacteroides R plasmids. Plasmid (1984) 3.19
Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost (1993) 3.12
The effect of regression to the mean in epidemiologic and clinical studies. Am J Epidemiol (1976) 3.12
Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial. JAMA (1994) 3.11
Bacteroides penicillinase. J Bacteriol (1968) 3.10
Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study. Circulation (1998) 2.88
Regulation of activated macrophage antimicrobial activities. Identification of lymphokines that cooperate with IFN-gamma for induction of resistance to infection. J Immunol (1988) 2.82
Plasma triglyceride level and mortality from coronary heart disease. N Engl J Med (1993) 2.80
Lipoprotein-cholesterol distributions in selected North American populations: the lipid research clinics program prevalence study. Circulation (1980) 2.72
The association of education with coronary heart disease mortality in the USSR Lipid Research Clinics Study. Int J Epidemiol (1993) 2.69
Mycobacterium bovis infections in San Diego: a clinicoepidemiologic study of 73 patients and a historical review of a forgotten pathogen. Medicine (Baltimore) (1993) 2.59
Immunochemical characterization of the "native" type III polysaccharide of group B Streptococcus. J Exp Med (1976) 2.55
HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes. Am J Transplant (2007) 2.50
Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction. Circulation (1999) 2.39
Rapid identification of Candida albicans septicemia in man by gas-liquid chromatography. J Clin Invest (1974) 2.29
Protection against gram-negative bacteremia and endotoxemia with human monoclonal IgM antibodies. Proc Natl Acad Sci U S A (1985) 2.26
Therapeutic concentrations of glucocorticoids suppress the antimicrobial activity of human macrophages without impairing their responsiveness to gamma interferon. J Clin Invest (1985) 2.22
Treatment of E. coli and klebsiella bacteremia in agranulocytic animals with antiserum to a UDP-gal epimerase-deficient mutant. J Immunol (1973) 2.18
Body mass index and body girths as predictors of mortality in black and white women. Arch Intern Med (1992) 2.17
Influence of colony type on susceptibility of gonococci to killing by human serum. J Immunol (1976) 2.14
Deactivation of macrophages with interleukin-4 is the key to the isolation of Tropheryma whippelii. J Infect Dis (1997) 2.08
Homology between clindamycin resistance plasmids in Bacteroides. Plasmid (1984) 2.00
The effect of ketoconazole on amphotericin B in a model of disseminated aspergillosis. J Infect Dis (1985) 1.94
Increased risk of coronary heart disease death in men with low total and low-density lipoprotein cholesterol in the Russian Lipid Research Clinics Prevalence Follow-up Study. Circulation (1993) 1.86
Norwalk gastrointestinal illness: an outbreak associated with swimming in a recreational lake and secondary person-to-person transmission. Am J Epidemiol (1982) 1.81
Pure red cell aplasia of long duration complicating major ABO-incompatible bone marrow transplantation. Blood (1990) 1.79
Infection imaging using whole-body FDG-PET. Eur J Nucl Med (2000) 1.76
Anaerobic infection of the paranasal sinuses. N Engl J Med (1974) 1.76
Serum carotenoids and coronary heart disease. The Lipid Research Clinics Coronary Primary Prevention Trial and Follow-up Study. JAMA (1994) 1.70
Factors associated with clinical leptospirosis: a population-based case-control study in the Seychelles (Indian Ocean). Int J Epidemiol (1999) 1.68
Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected US communities. The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb (1993) 1.65
Role of magnesium in the enzyme-linked immunosorbent assay for lipopolysaccharides of rough Escherichia coli strain J5 and Neisseria gonorrhoeae. J Infect Dis (1980) 1.64
Passive immunization against the local Shwartzman reaction. J Immunol (1972) 1.62
Neural substrates of facial emotion processing using fMRI. Brain Res Cogn Brain Res (2001) 1.61
Analysis of sugars in bacterial endotoxins by gas-liquid chromatography. Anal Biochem (1969) 1.60
Guidelines for quality assurance in multicenter trials: a position paper. Control Clin Trials (1998) 1.60
Induction of immunity against lethal Haemophilus influenzae type b infection by Escherichia coli core lipopolysaccharide. J Clin Invest (1982) 1.59
Role of blocking antibody in disseminated gonococcal infection. J Immunol (1978) 1.58
Simple method for culturing anaerobes. Appl Microbiol (1973) 1.58
Protection against lethality of E. coli endotoxin with "O" antiserum. Ann N Y Acad Sci (1966) 1.57
Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia. Lancet (1991) 1.57
The evolution of r factor. A study of a "preantibiotic" community in Borneo. N Engl J Med (1970) 1.56
Encystation and expression of cyst antigens by Giardia lamblia in vitro. Science (1987) 1.55
Antibody to cell wall glycolipid of Gram-negative bacteria: induction of immunity to bacteremia and endotoxemia. J Infect Dis (1977) 1.54
The relationship between lipids/lipoproteins and atherosclerosis in African Americans and whites: the Atherosclerosis Risk in Communities Study. Ann Epidemiol (1999) 1.50
Aspergillus fumigatus pneumonia in neutropenic patients receiving fluconazole for infection due to Candida species: is amphotericin B combined with fluconazole the appropriate answer? Clin Infect Dis (1994) 1.47
Role of meningococcal endotoxin in meningococcal purpura. J Exp Med (1974) 1.45
Identification of a conjugative R plasmid in Bacteroides ochraceus capable of transfer to Escherichia coli. Nature (1978) 1.43
Genetic analysis of clindamycin resistance in Bacteroides species. J Infect Dis (1983) 1.41
Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis (1991) 1.40
A randomized controlled trial of a physician-directed treatment program for low-income patients with high blood cholesterol: the Southeast Cholesterol Project. Arch Fam Med (1997) 1.40
Value of molecular epidemiologic analysis in a nosocomial methicillin-resistant Staphylococcus aureus outbreak. JAMA (1993) 1.40
Meningococcal disease in a pediatric population in San Diego County. Pediatr Infect Dis J (1993) 1.39
Immobilizing antibodies in urine. II. Prevention of ascending spread of Proteus mirabilis. Invest Urol (1974) 1.39
Neutralization of meningococcal endotoxin by antibody to core glycolipid. J Exp Med (1978) 1.38
The role of C9 in complement-mediated killing of Neisseria. J Immunol (1981) 1.35
Imputation strategies for missing data in a school-based multi-centre study: the Pathways study. Stat Med (2001) 1.33
Differentiation of neisseriaceae by isoenzyme electrophoresis. J Infect Dis (1983) 1.32
Treatment and prevention of intravascular coagulation with antiserum to endotoxin. J Infect Dis (1973) 1.32
In vitro susceptibility of fungi to killing by neutrophil granulocytes discriminates between primary pathogenicity and opportunism. J Clin Invest (1986) 1.31
A plaque assay on agar for detection of gram-negative bacilli sensitive to complement. J Immunol (1972) 1.30
Immunization against retrograde pyelonephritis. I. Production of an experimental model of severe ascending Escherichia coli pyelonephritis without bacteremia in rats. Am J Pathol (1974) 1.30
Intracranial suppurative disease. Early presumptive diagnosis and successful treatment without surgery. JAMA (1971) 1.29
Identification and localization of cyst-specific antigens of Giardia lamblia. Infect Immun (1989) 1.27
Long term follow up of prosthetic valve endocarditis: what characteristics identify patients who were treated successfully with antibiotics alone? Heart (1999) 1.26
Mycobacterium bovis as a significant cause of tuberculosis in children residing along the United States-Mexico border in the Baja California region. Pediatrics (2000) 1.26
Prevention of lethal pseudomonas bacteremia with epimerase-deficient E. coli antiserum. Trans Assoc Am Physicians (1975) 1.26
Estimation of body fat from anthropometry and bioelectrical impedance in Native American children. Int J Obes Relat Metab Disord (2000) 1.26
Malassezia fungemia in neonates and adults: complication of hyperalimentation. Rev Infect Dis (1988) 1.25
Activation of complement by serum-resistant Neisseria gonorrhoeae. Assembly of the membrane attack complex without subsequent cell death. J Exp Med (1982) 1.25
A study of particle sizes, shapes and toxicities present in a boivin-type endotoxic preparation. Ann N Y Acad Sci (1966) 1.24
Serum cholesterol, diet, and the decline in coronary heart disease mortality. Prev Med (1979) 1.24
Macrophage-induced cytotoxicity of N-methyl-D-aspartate receptor positive neurons involves excitatory amino acids rather than reactive oxygen intermediates and cytokines. Eur J Immunol (1992) 1.23